RxSight, Inc.
RXST
$25.84
$0.622.46%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 43.52% | 44.23% | 38.14% | 28.66% | 27.19% |
| Total Depreciation and Amortization | -14.59% | 1.58% | 5.14% | 9.98% | 5.49% |
| Total Amortization of Deferred Charges | -- | -100.00% | -99.30% | -74.07% | -48.01% |
| Total Other Non-Cash Items | 39.27% | 30.22% | 43.10% | 26.63% | 7.57% |
| Change in Net Operating Assets | -1.53% | -15.04% | -19.92% | 57.03% | -22.40% |
| Cash from Operations | 59.26% | 55.49% | 45.51% | 46.23% | 29.32% |
| Capital Expenditure | -13.00% | -72.50% | -63.27% | -117.83% | -101.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -442.14% | -607.45% | -116.31% | 375.77% | -140.89% |
| Cash from Investing | -348.78% | -489.72% | -110.67% | 317.02% | -155.39% |
| Total Debt Issued | -- | -100.00% | -100.00% | -- | -- |
| Total Debt Repaid | 99.90% | 99.86% | 49.91% | -50,865.25% | -49,613.22% |
| Issuance of Common Stock | 21.67% | 18.81% | 46.61% | -31.64% | 1,253.56% |
| Repurchase of Common Stock | -235.14% | -235.75% | -421.04% | -421.04% | -121.31% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 73.12% | 76.17% | 38.48% | -173.08% | -290.30% |
| Cash from Financing | 100.44% | 92.79% | 59.33% | -94.13% | 871.64% |
| Foreign Exchange rate Adjustments | -250.00% | -8.33% | -112.50% | 150.00% | 166.67% |
| Miscellaneous Cash Flow Adjustments | -- | -200.00% | -- | -- | -- |
| Net Change in Cash | 421.76% | 711.23% | 202.24% | 263.89% | 82.57% |
